Showing results (1201-1210 of 5,001) with videos related to
Sort By:
Pageof 501
FEBS Letters|October 21, 1991
Isolation of mitotic p34cdc2 apoenzyme from human cellsW Meikrantz, R P Feldman, M M Sladicka, et al.Haematologica|January 19, 2007
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcomePeter Dreger, Michael Rieger, Bärbel Seyfarth, et al.Vaccine|July 6, 2010
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine developmentDavid Franco, Wenjing Li, Fang Qing, et al.The Western Journal of Emergency Medicine|June 30, 2009
Unexpected arrest-related deaths in america: 12 months of open source surveillanceJeffrey D Ho, William G Heegaard, Donald M Dawes, et al.European Journal of Haematology|March 18, 2014
Azacitidine and low-dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts--a retrospective single-center experienceAleksandar Radujkovic, Sascha Dietrich, Tilmann Bochtler, et al.Gene Therapy|May 14, 1998
Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studiesX Li, A Gervaix, D Kang, et al.Leukemia|March 1, 1990
Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemiaJ Thaler, O Dietze, V Faber, et al.Proceedings of the National Academy of Sciences of the United States of America|January 31, 1995
Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1M Yu, M C Leavitt, M Maruyama, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myelomaK Neben, T Moehler, G Egerer, et al.Journal of Virology|March 29, 2003
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivoMartin Markowitz, Michael Louie, Arlene Hurley, et al.Pageof 501